Results: 299 Pages
-
Acute Myeloid Leukemia (AML) https://utswmed.org/conditions-treatments/leukemia/acute-myeloid-leukemia-aml/ Our physicians offer extensive expertise in diagnosing acute myeloid leukemia and identifying the most effective treatment plan, such as immunotherapy, chemotherapy...
-
Radiation Oncology https://utswmed.org/conditions-treatments/radiation-oncology/ Our faculty are recognized experts in radiotherapy and stereotactic radiosurgery, applying the latest available technology for the full spectrum of radiation therapy... -
Laser surgery offers hope for patients living with epilepsy and brain cancer https://utswmed.org/medblog/litt-surgery-brain-epilepsy/ Experts at UTSW are using laser interstitial thermal therapy (LITT) with iMRI, a minimally invasive alternative, to effectively treat epilepsy and deep-seated brain... -
Lung Cancer Treatments https://utswmed.org/conditions-treatments/lung-cancer/lung-cancer-treatments/ Our specialized lung cancer experts take lung cancer treatment to the next level with the latest clinical trials, immunotherapy, and advanced techniques to treat...
-
Mentoring Award (2023) https://utswmed.org/why-utsw/clinical-awards/past-clinical-excellence-award-winners/clinical-excellence-2023/mentoring-award/
-
Program Development Award (2022) https://utswmed.org/why-utsw/clinical-awards/past-clinical-excellence-award-winners/clinical-excellence-2022/program-development-award/
-
Takashi Eguchi, M.D., Ph.D. https://utswmed.org/doctors/takashi-eguchi/ Takashi Eguchi, M.D., Ph.D., is an Assistant Professor of Cardiovascular and Thoracic Surgery; he specializes in lung cancer surgery. -
New Knowledge, Innovations, and Research https://utswmed.org/patient-resources/nursing-excellence/2025-nursing-annual-report/new-knowledge-innovations-and-research/ -
Physician Update 2025 https://utswmed.org/heart/physician-update/ Review reports of our physicians and scientists from the most recent AHA Scientific Sessions. -
AFib and HFrEF: The Great Debates https://utswmed.org/heart/physician-update/2018/afib-and-hfref-great-debates/ 2018 AHA Scientific Sessions attendees debated optimal therapies for patients with atrial fibrillation and heart failure with reduced ejection fraction.